Related Experiment Video
Updated: Aug 12, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Fungal endocarditis: evidence in the world literature, 1965-1995
M E Ellis1, H Al-Abdely, A Sandridge
1Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates. michael.ellis@uaeu.ac.ae
Abstract:
We analyzed 270 cases of fungal endocarditis (FE) that occurred over 30 years. Vascular lines, non-cardiac surgery, immunocompromise and injection drug abuse are increasing risk factors. Delayed or mistaken diagnosis (82% of patients), long duration of symptoms before hospitalization (mean +/- standard deviation, 32+/-39 days) and extracardiac manifestations were characteristic. From 1988 onwards, 72% of patients were diagnosed preoperatively, compared with 43% before 1988 (P=.0001). The fungi most commonly isolated were Candida albicans (24% of patients), non-albicans species of Candida (24%), Apergillus species (24%), and Histoplasma species (6%); recently-emerged fungi accounted for 25% of cases. The mortality rate was 72%. Survival rates were better among patients who received combined surgical-antifungal treatment, were infected with Candida, and had univalvular involvement. Improvement in the survival rate (from <20% before 1974 to 41% currently) coincided with the introduction of echocardiography and with improved diagnostic acumen. Fungal endocarditis recurs in 30% of survivors. It is recommended that fungal endocarditis be diagnosed early through heightened diagnostic acumen; that patients be treated with combined lipid-based amphotericin B and early surgery; and that patients be followed up for > or =4 years while on prophylactic antifungal therapy.
Insights
Fungal endocarditis (FE) diagnosis improved with echocardiography, but mortality remains high at 72%. Early diagnosis and combined surgical-antifungal treatment improve survival rates for this serious infection.
Area of Science:
- Infectious Diseases
- Cardiology
- Mycology
Background:
- Fungal endocarditis (FE) is a rare but severe infection affecting heart valves.
- Risk factors for FE include vascular lines, surgery, immunocompromise, and injection drug use.
- Delayed diagnosis and extracardiac manifestations are common challenges in FE management.
Purpose of the Study:
- To analyze trends, risk factors, diagnosis, treatment, and outcomes of fungal endocarditis over 30 years.
- To identify factors associated with improved survival in fungal endocarditis patients.
Main Methods:
- Retrospective analysis of 270 fungal endocarditis cases over three decades.
- Comparison of diagnostic rates and outcomes before and after 1988.
- Identification of common fungal pathogens and assessment of treatment strategies.
Main Results:
- Increasing prevalence of risk factors like vascular lines and injection drug use.
- Significant improvement in preoperative diagnosis rates from 43% to 72% since 1988.
- Common fungi include Candida (albicans and non-albicans), Aspergillus, and Histoplasma; mortality rate is 72%.
Conclusions:
- Combined surgical-antifungal treatment, Candida infection, and univalvular involvement are linked to better survival.
- Survival rates have improved from <20% to 41% due to echocardiography and better diagnostics.
- Early diagnosis, prompt treatment with lipid-based amphotericin B and surgery, and long-term follow-up are crucial for managing FE.
More Related Videos
09:16Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
Published on: February 28, 2018
07:50An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
Published on: January 7, 2019
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Pericarditis I: Introduction
Pericarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies